MDXG · Mimedx Group, Inc.
$4.21
-0.07 (-1.52%)
At close · Aug 17
View the 10-K filed Feb 25, 2026
Customer concentration
— top 10 customers 22% of revenue
10 customers — 22% of revenue (the year ended December 31, 2025)
“For the years ended December 31, 2025, 2024, and 2023, our top ten customers accounted for 22%, 20% and 20%, respectively, of our net sales”
Key customers — 1% of revenue (the year ended December 31, 2025)
“net sales to all U.S. government accounts comprised approximately 1%, 1% and 2%, respectively, of our net sales.”
Market Cap
$622.40M
Shares
145.76M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ricci Whitlow | Chief Operating Officer | Terminated | 2026-04-16 |
| Dorothy E. Puhy | member of the Board of Directors | Appointed | 2024-03-04 |
| Tiffany P. Olson | member of the Board of Directors | Appointed | 2024-03-04 |
| William Phelan | Chief Accounting Officer | Retired | 2023-09-05 |
| Doug Rice | Chief Financial Officer | Appointed | 2023-09-05 |
| Pete Carlson | Chief Financial Officer | Resigned | 2023-07-05 |
| Doug Rice | Chief Financial Officer | Appointed | 2023-07-05 |
| Dr. Robert Stein | President of the Company’s Regenerative Medicine business unit | Terminated | 2023-06-20 |
| Joseph H. Capper | director | Appointed | 2023-01-30 |
| Joseph H. Capper | Chief Executive Officer | Appointed | 2023-01-30 |
| Joseph H. Capper | Board of Directors | Appointed | 2023-01-30 |
| Joseph H. Capper | Chief Executive Officer | Appointed | 2023-01-30 |
| Ricci S. Whitlow | Executive Vice President and Chief Operating Officer | Appointed | 2023-01-03 |
| Dr. Rohit Kashyap | President, Wound Care and Surgical | Resigned | 2022-12-16 |
| K. Todd Newton | Interim Executive | Appointed | 2022-09-16 |
| Timothy R. Wright | Chief Executive Officer | Terminated | 2022-09-16 |
| K. Todd Newton | Interim Chief Executive Officer | Appointed | 2022-09-16 |
| Timothy R. Wright | Chief Executive Officer | Terminated | 2022-09-06 |
| K. Todd Newton | interim Chief Executive Officer | Appointed | 2022-09-06 |
| Phyllis I. Gardner | director | Appointed | 2022-06-13 |
| James L. Bierman | director | Appointed | 2022-06-13 |
Key facts
CIK
1376339
CUSIP
602496101
13F (30d)
210 filings
210 filers
Visit website
Investor relations